|1||Not yet recruiting||
Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
† Indicates status has not been verified in more than two years